title: Osteoporosis: review of guidelines and consensus statements.
abstract: This activity is designed for physicians, pharmacists, nurses, health planners, directors of managed care organizations, and payers of health services.
  
  
  OBJECTIVE
  To understand current guidelines and consensus statements regarding the prevention, diagnosis, and treatment of osteoporosis.
  
  
  OBJECTIVE
  List four national or international organizations involved in the development of consensus statements regarding the prevention, diagnosis, and treatment of osteoporosis. 2. Discuss the significant differences among different countries regarding the prevention and treatment of osteoporosis. 3. List the major risk factors for osteoporosis. 4. Describe the differences in the application of bone mineral density scans, biochemical markers, and ultrasound in evaluating patients with suspected osteopenia and osteoporosis. 5. Distinguish between and briefly discuss therapeutic modalities used in primary prevention, secondary prevention, and treatment of osteoporosis. 6. Discuss the advantages and disadvantages of estrogen/hormone replacement therapy. 7. Describe alternatives to estrogen/hormone replacement therapy.
authors.affiliation: University of Tennessee College of Pharmacy, Memphis 38163, USA.
authors.forename: N
authors.initials: N
authors.lastname: Amarshi
authors.forename: J A
authors.initials: JA
authors.lastname: Scoggin
authors.forename: S
authors.initials: S
authors.lastname: Ensworth
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D003245:Consensus Statements as Topic; D017281:Cost of Illness; D019468:Disease Management; D004496:Education, Continuing; D015914:Estrogen Replacement Therapy; D005260:Female; D006801:Humans; D008875:Middle Aged; D010024:Osteoporosis / Q000175:diagnosis / Q000191:economics / Q000517:prevention & control* / Q000628:therapy; D017410:Practice Guidelines as Topic